Last reviewed · How we verify

NCT07201610

Non-invasive Diagnosis of Parkinson's Disease

Not yet recruiting Last updated 1 October 2025
What this trial tests

trial in Parkinsons Disease (PD) in 60 participants. Not yet recruiting.

Timeline
16 October 2025
Primary endpoint
16 December 2025
16 December 2025

Quick facts

Lead sponsorBlekinge Institute of Technology
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment60
Start date16 October 2025
Primary completion16 December 2025
Estimated completion16 December 2025

Conditions studied

Sponsor

Blekinge Institute of Technology

Who can join

Adults 60 to 80, any sex, with Parkinsons Disease (PD). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will investigate new, non-invasive methods to help diagnose Parkinson's disease. Researchers will use advanced eye imaging (hyperspectral retinal photography and OCT), computerized memory and thinking tests, and voice analysis to identify patterns linked to Parkinson's. The goal is to improve early and accurate diagnosis of Parkinson's disease without the need for spinal taps or invasive tests.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Parkinsons Disease (PD)

Currently open trials in the same condition.

Other Blekinge Institute of Technology trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07201610.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing